Printer-friendly format

Benefield Eye Care now offers the ALLEGRETTO WAVE™ with PerfectPulse Technology™, the only FDA-approved LASIK technology specifically built to address certain optical distortions that are the chief cause of nighttime vision and glare.

The ALLEGRETTO Wave's PerfectPulse Technology automatically determines each individual's unique pre-operative corneal curvature and provides a treatment that not only corrects nearsightedness and farsightedness, but also maintains the cornea's natural shape following treatment. Unlike other conventional lasers that can provide an incomplete treatment to the periphery of the cornea, PerfectPulse Technology applies additional treatment to the outer edges of the cornea to reduce the likelihood of induced optical imperfections.

As a result, clinical studies submitted to the U.S. Food and Drug Administration (FDA) in 2003 demonstrated that nearly 90 percent of patients had no increase in glare, halos and light sensitivity, and almost 20 percent of patients actually reported improved night-vision following treatment with this laser system.

"No other conventional LASIK treatment takes into account the unique curve and slope of each individual's cornea," said Dr. Don Benefield, Surgeon and Primary Provider at Benefield Eye Care, P.C. "Since we acquired the ALLEGRETTO WAVE, patients are more satisfied than ever with their post-LASIK vision, and glare and halo issues have been virtually eliminated."

Tags:

None